Earnings Feed
Sign Up
Home/Insiders/POPS RICHARD F
PR
SEC Insider//CIK 0001126490

POPS RICHARD F

CIK 00011264904 companiesWALTHAM, MA
SEC Profile

Transactions

50

Companies

4

Filings

3

CIK

0001126490

Recent Transactions

50 trades
  • Sale
    Alkermes plc.$ALKS

    Ordinary Shares

    2020-03-19$13.42/sh−10,346→ 823,748 total
  • Exercise/Conversion
    Alkermes plc.$ALKS

    Employee Stock Option (Right to Buy)

    2020-03-19−75,000→ 250,000 total
  • Sale
    Alkermes plc.$ALKS

    Ordinary Shares

    2020-03-19$15.04/sh−15,986→ 759,094 total
  • Exercise/Conversion
    Alkermes plc.$ALKS

    Ordinary Shares

    2020-03-19$11.74/sh+75,000→ 834,094 total
  • Sale
    Alkermes plc.$ALKS

    Ordinary Shares

    2020-03-19$14.51/sh−48,668→ 775,080 total
  • Exercise/Conversion
    Alkermes plc.$ALKS

    Restricted Stock Unit Award

    2013-05-20−8,125→ 16,250 total
  • Tax Payment
    Alkermes plc.$ALKS

    Ordinary Shares

    2013-05-20$31.04/sh−3,835→ 429,626 total
  • Exercise/Conversion
    Alkermes plc.$ALKS

    Restricted Stock Unit Award

    2013-05-20−8,125→ 16,250 total
  • Tax Payment
    Alkermes plc.$ALKS

    Ordinary Shares

    2013-05-20$31.04/sh−3,835→ 429,626 total
  • Exercise/Conversion
    Alkermes plc.$ALKS

    Ordinary Shares

    2013-05-20+8,125→ 433,461 total
  • Exercise/Conversion
    Alkermes plc.$ALKS

    Ordinary Shares

    2013-05-20+8,125→ 433,461 total
  • Exercise/Conversion
    Alkermes plc.$ALKS

    Restricted Stock Unit Award

    2013-05-17−8,125→ 8,125 total
  • Exercise/Conversion
    Alkermes plc.$ALKS

    Ordinary Shares

    2013-05-17+8,125→ 429,172 total
  • Tax Payment
    Alkermes plc.$ALKS

    Ordinary Shares

    2013-05-17$31.69/sh−3,836→ 425,336 total
  • Exercise/Conversion
    Alkermes plc.$ALKS

    Restricted Stock Unit Award

    2013-05-17−8,125→ 8,125 total
  • Exercise/Conversion
    Alkermes plc.$ALKS

    Ordinary Shares

    2013-05-17+8,125→ 429,172 total
  • Tax Payment
    Alkermes plc.$ALKS

    Ordinary Shares

    2013-05-17$31.69/sh−3,836→ 425,336 total
  • Exercise/Conversion
    Alkermes plc.$ALKS

    Common Stock

    2012-01-27+25,000→ 348,727 total
  • Exercise/Conversion
    Alkermes plc.$ALKS

    Restricted Stock Award

    2012-01-27−25,000→ 0 total
  • Tax Payment
    Alkermes plc.$ALKS

    Common Stock

    2012-01-27$19.10/sh−8,045→ 340,682 total
  • Sale
    Alkermes plc.$ALKS

    Common Stock

    2011-10-03$14.25/sh−89,418→ 334,936 total
  • Sale
    Alkermes plc.$ALKS

    Common Stock

    2011-10-03$15.07/sh−10,582→ 324,354 total
  • Sale
    Alkermes plc.$ALKS

    Common Stock

    2011-10-03$14.25/sh−89,418→ 334,936 total
  • Sale
    Alkermes plc.$ALKS

    Common Stock

    2011-10-03$15.07/sh−10,582→ 324,354 total
  • Tax Payment
    ALKERMES INC

    Common Stock

    2011-06-01$17.87/sh−2,610→ 428,529 total
  • Tax Payment
    ALKERMES INC

    Common Stock

    2011-05-27$18.16/sh−1,984→ 431,139 total
  • Tax Payment
    ALKERMES INC

    Common Stock

    2011-05-27$18.16/sh−1,984→ 431,139 total
  • Award
    NEUROCRINE BIOSCIENCES INC$NBIX

    Stock Option

    2011-05-25+15,000→ 15,000 total
  • Award
    NEUROCRINE BIOSCIENCES INC$NBIX

    Stock Option

    2011-05-25+15,000→ 15,000 total
  • Award
    ALKERMES INC

    Employee Stock Option (Right to Buy)

    2011-05-20+400,000→ 400,000 total
  • Award
    ALKERMES INC

    Restricted Stock Unit Award

    2011-05-20+32,500→ 32,500 total
  • Exercise/Conversion
    ALKERMES INC

    Common Stock

    2011-05-17+8,125→ 436,375 total
  • Tax Payment
    ALKERMES INC

    Common Stock

    2011-05-17$18.09/sh−3,252→ 433,123 total
  • Exercise/Conversion
    ALKERMES INC

    Restricted Stock Unit Award

    2011-05-17−8,125→ 24,375 total
  • Tax Payment
    ALKERMES INC

    Common Stock

    2011-05-17$18.09/sh−3,252→ 433,123 total
  • Exercise/Conversion
    ALKERMES INC

    Common Stock

    2011-05-17+8,125→ 436,375 total
  • Exercise/Conversion
    ALKERMES INC

    Restricted Stock Unit Award

    2011-05-17−8,125→ 24,375 total
  • Disposition to Issuer
    NEUROCRINE BIOSCIENCES INC$NBIX

    Stock Option (right to buy)

    2009-08-28$0.00/sh−12,000→ 0 total
  • Disposition to Issuer
    NEUROCRINE BIOSCIENCES INC$NBIX

    Stock Option (right to buy)

    2009-08-28$0.00/sh−12,000→ 0 total
  • Disposition to Issuer
    NEUROCRINE BIOSCIENCES INC$NBIX

    Stock Option (right to buy)

    2009-08-28$0.00/sh−12,000→ 0 total
  • Disposition to Issuer
    NEUROCRINE BIOSCIENCES INC$NBIX

    Stock Option (right to buy)

    2009-08-28$0.00/sh−12,000→ 0 total
  • Tax Payment
    ALKERMES INC

    Common Stock

    2009-06-01$8.11/sh−2,280→ 442,216 total
  • Award
    NEUROCRINE BIOSCIENCES INC$NBIX

    Stock Option

    2009-05-29+15,000→ 15,000 total
  • Award
    NEUROCRINE BIOSCIENCES INC$NBIX

    Stock Option

    2009-05-29+15,000→ 15,000 total
  • Award
    EPIRUS Biopharmaceuticals, Inc.

    Non-Qualified Stock Option (right to buy)

    2008-05-29+12,500→ 12,500 total
  • Award
    EPIRUS Biopharmaceuticals, Inc.

    Non-Qualified Stock Option (right to buy)

    2008-05-29+12,500→ 12,500 total
  • Exercise/Conversion
    ALKERMES INC

    Non-Qualified Stock Option (right to buy)

    2007-07-10$14.56/sh−18,098→ 36,198 total
  • Sale
    ALKERMES INC

    Common Stock

    2007-07-10$14.56/sh−18,098→ 404,695 total
  • Exercise/Conversion
    ALKERMES INC

    Common Stock

    2007-07-10$7.94/sh+18,098→ 422,793 total
  • Award
    ALKERMES INC

    Non-Qualified Stock Option (right to buy)

    2006-12-12+120,000→ 120,000 total

Companies

4

Recent Filings

3

Address

852 WINTER ST.

WALTHAM, MA, 02451

View on SEC.gov